Quarterly results · MDRC
MODERN DIAGNOSTIC & RESEARCH C reported revenue of ₹22.5 cr and net profit of ₹3 cr in Q1 FY26 (quarter ended 30 Jun 2025). Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated automatically from exchange filings.
| Quarter | Q1 FY26 |
|---|---|
| Quarter ended | 30 Jun 2025 |
| Revenue | ₹22.5 cr |
| Revenue YoY | — |
| Operating profit | ₹4.66 cr |
| Operating margin | 20.7% |
| Net profit | ₹3 cr |
| Net profit YoY | — |
| Net profit QoQ | — |
| Net margin | 13.3% |
| Basic EPS | ₹1.99 |
| TTM revenue | — |
| TTM net profit | — |
| TTM net margin | — |
MODERN DIAGNOSTIC & RESEARCH C (MDRC) has reported its Q1 FY26 results for the quarter ended 2025-06-30. The company posted revenue of ₹22.5 cr and a net profit of ₹3 cr, translating into earnings per share of ₹1.99.
Operating profit for the quarter stood at ₹4.66 cr, an operating margin of 20.7%.
Revenue
₹22.5 cr
— YoY
Net profit
₹3 cr
— YoY
Operating profit
₹4.66 cr
— YoY
EPS
₹1.99
— YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY262025-06-30 | ₹22.5 cr | ₹4.66 cr | ₹3 cr | 20.7% | 13.3% | ₹1.99 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
| Particulars | Q1 FY262025-06-30 |
|---|---|
| Revenue / Sales | ₹22.5 cr |
| Total expenses | ₹17.84 cr |
| Gross profit | ₹16.02 cr |
| Operating profit (EBIT) | ₹4.66 cr |
| Operating margin | 20.7% |
| Interest cost | ₹0.48 cr |
| Profit before tax | ₹4.28 cr |
| Tax expense | ₹1.28 cr |
| Effective tax rate | 29.9% |
| Net profit (PAT) | ₹3 cr |
| Net profit margin | 13.3% |
| Basic EPS | ₹1.99 |
| Diluted EPS | ₹1.99 |
Full-year performance for MODERN DIAGNOSTIC & RESEARCH C, useful for reading each quarter in context.
| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|---|---|---|---|
| Revenue / Sales | ₹83.11 cr | ₹77.95 cr | ₹67.13 cr | ₹56.28 cr |
| Total expenses | ₹75.36 cr | ₹64.02 cr | ₹59.87 cr | ₹60.98 cr |
| Gross profit | ₹56.21 cr | ₹56.37 cr | ₹47.08 cr | ₹35.45 cr |
| Operating profit (EBIT) | ₹7.75 cr | ₹13.93 cr | ₹7.26 cr | -₹4.7 cr |
| Operating margin | 9.3% | 17.9% | 10.8% | -8.4% |
| Interest cost | ₹2.44 cr | ₹1.85 cr | ₹1.79 cr | ₹1.38 cr |
| Profit before tax | ₹5.99 cr | ₹12.87 cr | ₹6.86 cr | -₹5.94 cr |
| Tax expense | ₹0.74 cr | ₹3.86 cr | ₹1.07 cr | -₹0.21 cr |
| Effective tax rate | 12.3% | 30.0% | 15.6% | 3.5% |
| Net profit (PAT) | ₹5.25 cr | ₹9.01 cr | ₹5.79 cr | -₹5.73 cr |
| Net profit margin | 6.3% | 11.6% | 8.6% | -10.2% |
| Basic EPS | — | ₹5.97 | ₹3.84 | ₹-3.80 |
| Diluted EPS | — | ₹5.97 | ₹3.84 | ₹-3.80 |
Topline for Q1 FY26 came in at ₹22.5 cr.
Total expenses for the quarter were ₹17.84 cr, or 79.3% of revenue.
Net profit of ₹3 cr works out to a net margin of 13.3%.
Below the operating line, MODERN DIAGNOSTIC & RESEARCH C reported profit before tax of ₹4.28 cr, a tax charge of ₹1.28 cr (effective rate 29.9%), interest cost of ₹0.48 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
On a full-year basis, FY26 revenue was ₹83.11 cr with net profit of ₹5.25 cr and EPS of —, versus the prior year where revenue grew +6.6% and profit declined -41.7%.
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
MODERN DIAGNOSTIC & RESEARCH C has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
No results report published for MDRC yet — our desk covers each quarter within minutes of the filing.
In Q1 FY26 (quarter ended 30 Jun 2025), MODERN DIAGNOSTIC & RESEARCH C reported revenue of ₹22.5 cr and net profit of ₹3 cr. EPS stood at ₹1.99.
MODERN DIAGNOSTIC & RESEARCH C posted a net profit margin of 13.3% and an operating margin of 20.7% in Q1 FY26. On a trailing twelve-month basis, revenue is — and net profit —.
Sequential comparison for MDRC will appear once two consecutive quarters are filed.
MODERN DIAGNOSTIC & RESEARCH C has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Results coverage for MDRC will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the MDRC stock page.
For FY26, MODERN DIAGNOSTIC & RESEARCH C reported full-year revenue of ₹83.11 cr and net profit of ₹5.25 cr, with EPS of —.
Past results dates for MDRC will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
